In line with this notion, COX-2 positron emission tomography (PET) imaging—a tool for monitoring in vivo COX-2 upregulation—is an in-progress avenue for the identification of MDD subgroups with active neuroinflammation [51]. Here, PTGS2 is linked to major depressive disorder.